Literature DB >> 27076593

Multicentre chest computed tomography standardisation in children and adolescents with cystic fibrosis: the way forward.

Wieying Kuo1, Mariette P C Kemner-van de Corput2, Adria Perez-Rovira3, Marleen de Bruijne4, Isabelle Fajac5, Harm A W M Tiddens1, Marcel van Straten6.   

Abstract

Progressive cystic fibrosis (CF) lung disease is the main cause of mortality in CF patients. CF lung disease starts in early childhood. With current standards of care, respiratory function remains largely normal in children and more sensitive outcome measures are needed to monitor early CF lung disease. Chest CT is currently the most sensitive imaging modality to monitor pulmonary structural changes in children and adolescents with CF. To quantify structural lung disease reliably among multiple centres, standardisation of chest CT protocols is needed. SCIFI CF (Standardised Chest Imaging Framework for Interventions and Personalised Medicine in CF) was founded to characterise chest CT image quality and radiation doses among 16 participating European CF centres in 10 different countries. We aimed to optimise CT protocols in children and adolescents among several CF centres. A large variety was found in CT protocols, image quality and radiation dose usage among the centres. However, the performance of all CT scanners was found to be very similar, when taking spatial resolution and radiation dose into account. We conclude that multicentre standardisation of chest CT in children and adolescents with CF can be achieved for future clinical trials.
Copyright ©ERS 2016.

Entities:  

Mesh:

Year:  2016        PMID: 27076593     DOI: 10.1183/13993003.01601-2015

Source DB:  PubMed          Journal:  Eur Respir J        ISSN: 0903-1936            Impact factor:   16.671


  8 in total

Review 1.  Chest imaging in cystic fibrosis studies: What counts, and can be counted?

Authors:  Rhonda Szczesniak; Lidija Turkovic; Eleni-Rosalina Andrinopoulou; Harm A W M Tiddens
Journal:  J Cyst Fibros       Date:  2016-12-28       Impact factor: 5.482

Review 2.  Current state of the art MRI for the longitudinal assessment of cystic fibrosis.

Authors:  Jason C Woods; Jim M Wild; Mark O Wielpütz; John P Clancy; Hiroto Hatabu; Hans-Ulrich Kauczor; Edwin J R van Beek; Talissa A Altes
Journal:  J Magn Reson Imaging       Date:  2019-12-17       Impact factor: 4.813

3.  Design and application of an MR reference phantom for multicentre lung imaging trials.

Authors:  Simon M F Triphan; Jürgen Biederer; Kerstin Burmester; Iven Fellhauer; Claus F Vogelmeier; Rudolf A Jörres; Hans-Ulrich Kauczor; Claus P Heußel; Mark O Wielpütz; Bertram J Jobst
Journal:  PLoS One       Date:  2018-07-05       Impact factor: 3.240

4.  A comprehensive assessment of physical image quality of five different scanners for head CT imaging as clinically used at a single hospital centre-A phantom study.

Authors:  Patrizio Barca; Fabio Paolicchi; Giacomo Aringhieri; Federica Palmas; Daniela Marfisi; Maria Evelina Fantacci; Davide Caramella; Marco Giannelli
Journal:  PLoS One       Date:  2021-01-14       Impact factor: 3.240

5.  Chest X-rays are less sensitive than multiple breath washout examinations when it comes to detecting early cystic fibrosis lung disease.

Authors:  Marcus Svedberg; Henrik Imberg; Per Gustafsson; Mela Brink; Håkan Caisander; Anders Lindblad
Journal:  Acta Paediatr       Date:  2022-02-24       Impact factor: 4.056

6.  Assessment of early lung disease in young children with CF: A comparison between pressure-controlled and free-breathing chest computed tomography.

Authors:  Merel C J Oudraad; Wieying Kuo; Tim Rosenow; Eleni-Rosalina Andrinopoulou; Stephen M Stick; Harm A W M Tiddens
Journal:  Pediatr Pulmonol       Date:  2020-03-02

7.  Analysis of Granulomatous Lymphocytic Interstitial Lung Disease Using Two Scoring Systems for Computed Tomography Scans-A Retrospective Cohort Study.

Authors:  Jennifer J Meerburg; Ieneke J C Hartmann; Sigune Goldacker; Ulrich Baumann; Annette Uhlmann; Eleni-Rosalina Andrinopoulou; Mariette P C Kemner V/D Corput; Klaus Warnatz; Harm A W M Tiddens
Journal:  Front Immunol       Date:  2020-10-30       Impact factor: 7.561

8.  Chest computed tomography outcomes in a randomized clinical trial in cystic fibrosis: Lessons learned from the first ataluren phase 3 study.

Authors:  Harm A W M Tiddens; Eleni-Rosalina Andrinopoulou; Joe McIntosh; J Stuart Elborn; Eitan Kerem; Nynke Bouma; Jochem Bosch; Mariette Kemner-van de Corput
Journal:  PLoS One       Date:  2020-11-03       Impact factor: 3.240

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.